Laurent Peyrin-Biroulet to Molecular Targeted Therapy
This is a "connection" page, showing publications Laurent Peyrin-Biroulet has written about Molecular Targeted Therapy.
Connection Strength
0.107
-
JAK inhibition in inflammatory bowel disease. Expert Rev Clin Immunol. 2017 07; 13(7):693-703.
Score: 0.085
-
PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue. Int J Mol Sci. 2017 Jun 15; 18(6).
Score: 0.022